This suggests that inhibition of Smo might result in the restoration of Numb and miR-326 expression, could possibly eradicate the number of CD34+ LSCs and, thus, CML pathogenesis. The gene discussed is NUMB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.